Cigna Group CEO Transition and Earnings Outlook
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Mar 03 2026
0mins
Should l Buy CI?
Source: seekingalpha
- CEO Transition: Cigna Group announced that CEO David Cordani will retire on July 1, with current President and COO Brian Evanko succeeding him, ensuring a smooth leadership transition aimed at maintaining business continuity and strategic execution.
- New Board Role: Cordani will become the executive chair of Cigna Group's Board of Directors, leveraging his extensive experience to guide the company's future development, thereby strengthening the board's strategic decision-making capabilities and ensuring competitiveness in the industry.
- Earnings Outlook Reaffirmed: Cigna Group reaffirmed its projected adjusted income from operations of at least $30.25 per share for 2026, indicating confidence in future profitability while reflecting its robust performance in the market.
- Segment Business Targets: The company anticipates at least $6.9 billion in pre-tax adjusted income from operations for Evernorth and at least $4.5 billion for Cigna Healthcare in 2026, showcasing growth potential and market positioning across its various business segments.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy CI?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on CI
Wall Street analysts forecast CI stock price to rise
16 Analyst Rating
14 Buy
2 Hold
0 Sell
Strong Buy
Current: 267.320
Low
300.00
Averages
335.63
High
378.00
Current: 267.320
Low
300.00
Averages
335.63
High
378.00
About CI
The Cigna Group is a global health company. The Company has two growth platforms: Evernorth Health Services and Cigna Healthcare. Evernorth Health Services includes its Pharmacy Benefit Services and Specialty and Care Services operating segments, which provide independent and coordinated health solutions and capabilities to enable the healthcare system to work better and help people live richer, healthier lives. Cigna Healthcare includes the U.S. Healthcare and International Health operating segments, which provide comprehensive medical plan services and coordinated solutions to clients and customers. Its Other Operations include corporate-owned life insurance (COLI), the Company's run-off operations and other non-strategic businesses. Specialty and Care Services provides specialty drugs for the treatment of complex and rare diseases, specialty distribution of pharmaceuticals and medical supplies, and clinical programs to help its clients.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
- Earnings Release Schedule: The Cigna Group will release its Q1 2026 financial results on April 30, 2026, no later than 6:30 a.m. ET, demonstrating the company's commitment to transparency and timely communication with stakeholders.
- Conference Call Details: Management will host a conference call at 8:30 a.m. ET on the same day, with participants encouraged to dial in by 8:15 a.m., reflecting the company's focus on investor relations and effective information dissemination.
- Replay and Webcast Availability: A replay of the conference call will be accessible from 12:30 p.m. ET on April 30 until 10:59 p.m. ET on May 14, and the call will also be available via live internet webcast, enhancing investor engagement and access to information.
- Investor Relations Information: Cigna Group will provide a news release and financial supplement on its website's Investor Relations section, ensuring investors have timely access to the latest updates, which underscores the company's commitment to transparency and investor communication.
See More
- Earnings Release Schedule: The Cigna Group will release its Q1 2026 financial results on April 30, 2026, no later than 6:30 a.m. ET, reflecting the company's commitment to transparency.
- Conference Call Details: Management will host a conference call at 8:30 a.m. ET on the same day, with participants encouraged to dial in by 8:15 a.m. ET to ensure timely access to financial information, thereby enhancing investor confidence.
- Replay and Webcast Availability: A replay of the conference call will be available from 12:30 p.m. ET on April 30 until 10:59 p.m. ET on May 14, and the call will also be accessible via a live webcast on the company's website, further improving information accessibility.
- Company Background: The Cigna Group is a global health company focused on improving health through innovative solutions, maintaining over 185 million customer relationships worldwide, showcasing its extensive influence in the global market.
See More
- Investment and Impact: The Cigna Group Foundation invested over $3 million across 10 states, supporting 22 nonprofit partners to assist 8,000 veterans in gaining stable housing and integrated support services, significantly improving veterans' quality of life.
- Housing Stability Improvement: By providing 12 new homes and 116 housing modifications, nearly all veterans receiving housing assistance experienced positive life changes, indicating the program's effectiveness in addressing housing instability.
- Employee Volunteerism: In 2025, over 200 employee volunteers contributed more than 1,000 hours to support local nonprofits, showcasing the company's commitment to enhancing veteran mental health through community engagement and social responsibility.
- Long-term Commitment: The Cigna Group Foundation has pledged $27 million over three years to improve veteran mental health, with $9 million specifically allocated to enhancing veterans' mental wellbeing through housing stability, reflecting the company's ongoing dedication to social responsibility.
See More
- Decline in Coverage: A KFF survey reveals that approximately 9% of ACA marketplace enrollees lost their insurance after the expiration of subsidies, indicating a direct impact of rising premiums that may lead to more individuals facing healthcare cost burdens.
- Significant Premium Increases: With the lapse of enhanced premium tax credits, average premiums for ACA enrollees are expected to double by 2026, exacerbating financial pressures on households and affecting their spending capabilities.
- Voter Sentiment Shift: The survey indicates that 54% of returning ACA enrollees blame rising healthcare costs on congressional Republicans and Trump, suggesting that healthcare affordability could become a pivotal political issue in the upcoming midterm elections, influencing voter turnout.
- Household Financial Strain: About 55% of ACA enrollees report cutting back on essential expenses like food and clothing to afford healthcare costs, highlighting the profound impact of medical expenses on household finances, which could lead to higher unemployment rates and economic instability.
See More

Company Performance: Cigna has reported an increase in market performance, indicating a positive trend in its financial health.
Target Price Adjustment: The target price for Cigna's stock has been raised to $358 from a previous $307, reflecting increased investor confidence.
See More
- Program Launch: Eli Lilly has introduced the 'Employer Connect' platform aimed at helping more employers cover obesity drugs, addressing a major barrier to patient access and expected to enhance employee drug accessibility.
- Price Transparency: Through this platform, employers can purchase a multi-dose form of Zepbound at a net discounted price of $449 per month, avoiding traditional rebate models, thereby providing clearer visibility on drug pricing for employers.
- Flexible Benefits Design: Employers can choose from 15 different third-party administrators to design benefits tailored to their budget and workforce needs, offering comprehensive obesity management services including telehealth, nutrition, and lifestyle support.
- Government Insurance Coverage: Under landmark deals with President Trump, Medicare will cover obesity drugs for the first time, which is expected to further expand drug accessibility and benefit more patients.
See More










